English
简体中文
Total: £ 56.28
Published Date: 2026-01-22 | Pages: 111 | Tables: 113 | Medical Care
The global Extracellular Vesicle Therapy market was valued at US$ 988 million in 2025 and is anticipated to reach US$ 1958 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.
The North American market for Extracellular Vesicle Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Extracellular Vesicle Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Extracellular Vesicle Therapy in Cancer Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Extracellular Vesicle Therapy include FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Extracellular Vesicle Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracellular Vesicle Therapy. The Extracellular Vesicle Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracellular Vesicle Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracellular Vesicle Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
FUJIFILM Diosynth Biotechnologies
EV Therapeutics
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Segment by Type
Exosome-based
Microvesicle-based
Segment by Application
Cancer Treatment
Regenerative Medicine
Drug Delivery
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Extracellular Vesicle Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicle Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Exosome-based
1.2.3 Microvesicle-based
1.3 Market by Application
1.3.1 Global Extracellular Vesicle Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer Treatment
1.3.3 Regenerative Medicine
1.3.4 Drug Delivery
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicle Therapy Market Perspective (2021–2032)
2.2 Global Extracellular Vesicle Therapy Growth Trends by Region
2.2.1 Global Extracellular Vesicle Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Extracellular Vesicle Therapy Historic Market Size by Region (2021–2026)
2.2.3 Extracellular Vesicle Therapy Forecasted Market Size by Region (2027–2032)
2.3 Extracellular Vesicle Therapy Market Dynamics
2.3.1 Extracellular Vesicle Therapy Industry Trends
2.3.2 Extracellular Vesicle Therapy Market Drivers
2.3.3 Extracellular Vesicle Therapy Market Challenges
2.3.4 Extracellular Vesicle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicle Therapy Players by Revenue
3.1.1 Global Top Extracellular Vesicle Therapy Players by Revenue (2021–2026)
3.1.2 Global Extracellular Vesicle Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Extracellular Vesicle Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicle Therapy Revenue
3.4 Global Extracellular Vesicle Therapy Market Concentration Ratio
3.4.1 Global Extracellular Vesicle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicle Therapy Revenue in 2025
3.5 Global Key Players of Extracellular Vesicle Therapy Head Offices and Areas Served
3.6 Global Key Players of Extracellular Vesicle Therapy, Products and Applications
3.7 Global Key Players of Extracellular Vesicle Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Extracellular Vesicle Therapy Breakdown Data by Type
4.1 Global Extracellular Vesicle Therapy Historic Market Size by Type (2021–2026)
4.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Type (2027–2032)
5 Extracellular Vesicle Therapy Breakdown Data by Application
5.1 Global Extracellular Vesicle Therapy Historic Market Size by Application (2021–2026)
5.2 Global Extracellular Vesicle Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Extracellular Vesicle Therapy Market Size (2021–2032)
6.2 North America Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Extracellular Vesicle Therapy Market Size by Country (2021–2026)
6.4 North America Extracellular Vesicle Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicle Therapy Market Size (2021–2032)
7.2 Europe Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Extracellular Vesicle Therapy Market Size by Country (2021–2026)
7.4 Europe Extracellular Vesicle Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicle Therapy Market Size (2021–2032)
8.2 Asia-Pacific Extracellular Vesicle Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Extracellular Vesicle Therapy Market Size (2021–2032)
9.2 Latin America Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Extracellular Vesicle Therapy Market Size by Country (2021–2026)
9.4 Latin America Extracellular Vesicle Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicle Therapy Market Size (2021–2032)
10.2 Middle East & Africa Extracellular Vesicle Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Diosynth Biotechnologies
11.1.1 FUJIFILM Diosynth Biotechnologies Company Details
11.1.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.1.3 FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Introduction
11.1.4 FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.1.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.2 EV Therapeutics
11.2.1 EV Therapeutics Company Details
11.2.2 EV Therapeutics Business Overview
11.2.3 EV Therapeutics Extracellular Vesicle Therapy Introduction
11.2.4 EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.2.5 EV Therapeutics Recent Development
11.3 Cellular Biomedicine Group
11.3.1 Cellular Biomedicine Group Company Details
11.3.2 Cellular Biomedicine Group Business Overview
11.3.3 Cellular Biomedicine Group Extracellular Vesicle Therapy Introduction
11.3.4 Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.3.5 Cellular Biomedicine Group Recent Development
11.4 Codiak BioSciences
11.4.1 Codiak BioSciences Company Details
11.4.2 Codiak BioSciences Business Overview
11.4.3 Codiak BioSciences Extracellular Vesicle Therapy Introduction
11.4.4 Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.4.5 Codiak BioSciences Recent Development
11.5 Coya Therapeutics
11.5.1 Coya Therapeutics Company Details
11.5.2 Coya Therapeutics Business Overview
11.5.3 Coya Therapeutics Extracellular Vesicle Therapy Introduction
11.5.4 Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.5.5 Coya Therapeutics Recent Development
11.6 Curexsys
11.6.1 Curexsys Company Details
11.6.2 Curexsys Business Overview
11.6.3 Curexsys Extracellular Vesicle Therapy Introduction
11.6.4 Curexsys Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.6.5 Curexsys Recent Development
11.7 Evox Therapeutics
11.7.1 Evox Therapeutics Company Details
11.7.2 Evox Therapeutics Business Overview
11.7.3 Evox Therapeutics Extracellular Vesicle Therapy Introduction
11.7.4 Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.7.5 Evox Therapeutics Recent Development
11.8 ExoCoBio
11.8.1 ExoCoBio Company Details
11.8.2 ExoCoBio Business Overview
11.8.3 ExoCoBio Extracellular Vesicle Therapy Introduction
11.8.4 ExoCoBio Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.8.5 ExoCoBio Recent Development
11.9 ILIAS Biologics
11.9.1 ILIAS Biologics Company Details
11.9.2 ILIAS Biologics Business Overview
11.9.3 ILIAS Biologics Extracellular Vesicle Therapy Introduction
11.9.4 ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.9.5 ILIAS Biologics Recent Development
11.10 Rion
11.10.1 Rion Company Details
11.10.2 Rion Business Overview
11.10.3 Rion Extracellular Vesicle Therapy Introduction
11.10.4 Rion Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.10.5 Rion Recent Development
11.11 SHIFTBIO
11.11.1 SHIFTBIO Company Details
11.11.2 SHIFTBIO Business Overview
11.11.3 SHIFTBIO Extracellular Vesicle Therapy Introduction
11.11.4 SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (2021–2026)
11.11.5 SHIFTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Extracellular Vesicle Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Exosome-based
Table 3. Key Players of Microvesicle-based
Table 4. Global Extracellular Vesicle Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Extracellular Vesicle Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Extracellular Vesicle Therapy Market Share by Region (2021–2026)
Table 8. Global Extracellular Vesicle Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Extracellular Vesicle Therapy Market Share by Region (2027–2032)
Table 10. Extracellular Vesicle Therapy Market Trends
Table 11. Extracellular Vesicle Therapy Market Drivers
Table 12. Extracellular Vesicle Therapy Market Challenges
Table 13. Extracellular Vesicle Therapy Market Restraints
Table 14. Global Extracellular Vesicle Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Extracellular Vesicle Therapy Market Share by Players (2021–2026)
Table 16. Global Top Extracellular Vesicle Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Extracellular Vesicle Therapy Revenue, 2025
Table 17. Ranking of Global Top Extracellular Vesicle Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Extracellular Vesicle Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Extracellular Vesicle Therapy, Headquarters and Area Served
Table 20. Global Key Players of Extracellular Vesicle Therapy, Products and Applications
Table 21. Global Key Players of Extracellular Vesicle Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Extracellular Vesicle Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Extracellular Vesicle Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Extracellular Vesicle Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Extracellular Vesicle Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Extracellular Vesicle Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Extracellular Vesicle Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Extracellular Vesicle Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Extracellular Vesicle Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Extracellular Vesicle Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Extracellular Vesicle Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. FUJIFILM Diosynth Biotechnologies Company Details
Table 47. FUJIFILM Diosynth Biotechnologies Business Overview
Table 48. FUJIFILM Diosynth Biotechnologies Extracellular Vesicle Therapy Product
Table 49. FUJIFILM Diosynth Biotechnologies Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 50. FUJIFILM Diosynth Biotechnologies Recent Development
Table 51. EV Therapeutics Company Details
Table 52. EV Therapeutics Business Overview
Table 53. EV Therapeutics Extracellular Vesicle Therapy Product
Table 54. EV Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 55. EV Therapeutics Recent Development
Table 56. Cellular Biomedicine Group Company Details
Table 57. Cellular Biomedicine Group Business Overview
Table 58. Cellular Biomedicine Group Extracellular Vesicle Therapy Product
Table 59. Cellular Biomedicine Group Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 60. Cellular Biomedicine Group Recent Development
Table 61. Codiak BioSciences Company Details
Table 62. Codiak BioSciences Business Overview
Table 63. Codiak BioSciences Extracellular Vesicle Therapy Product
Table 64. Codiak BioSciences Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 65. Codiak BioSciences Recent Development
Table 66. Coya Therapeutics Company Details
Table 67. Coya Therapeutics Business Overview
Table 68. Coya Therapeutics Extracellular Vesicle Therapy Product
Table 69. Coya Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 70. Coya Therapeutics Recent Development
Table 71. Curexsys Company Details
Table 72. Curexsys Business Overview
Table 73. Curexsys Extracellular Vesicle Therapy Product
Table 74. Curexsys Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 75. Curexsys Recent Development
Table 76. Evox Therapeutics Company Details
Table 77. Evox Therapeutics Business Overview
Table 78. Evox Therapeutics Extracellular Vesicle Therapy Product
Table 79. Evox Therapeutics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 80. Evox Therapeutics Recent Development
Table 81. ExoCoBio Company Details
Table 82. ExoCoBio Business Overview
Table 83. ExoCoBio Extracellular Vesicle Therapy Product
Table 84. ExoCoBio Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 85. ExoCoBio Recent Development
Table 86. ILIAS Biologics Company Details
Table 87. ILIAS Biologics Business Overview
Table 88. ILIAS Biologics Extracellular Vesicle Therapy Product
Table 89. ILIAS Biologics Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 90. ILIAS Biologics Recent Development
Table 91. Rion Company Details
Table 92. Rion Business Overview
Table 93. Rion Extracellular Vesicle Therapy Product
Table 94. Rion Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 95. Rion Recent Development
Table 96. SHIFTBIO Company Details
Table 97. SHIFTBIO Business Overview
Table 98. SHIFTBIO Extracellular Vesicle Therapy Product
Table 99. SHIFTBIO Revenue in Extracellular Vesicle Therapy Business (US$ Million), 2021–2026
Table 100. SHIFTBIO Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Extracellular Vesicle Therapy Picture
Figure 2. Global Extracellular Vesicle Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Extracellular Vesicle Therapy Market Share by Type: 2025 vs 2032
Figure 4. Exosome-based Features
Figure 5. Microvesicle-based Features
Figure 6. Global Extracellular Vesicle Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Extracellular Vesicle Therapy Market Share by Application: 2025 vs 2032
Figure 8. Cancer Treatment Case Studies
Figure 9. Regenerative Medicine Case Studies
Figure 10. Drug Delivery Case Studies
Figure 11. Other Case Studies
Figure 12. Extracellular Vesicle Therapy Report Years Considered
Figure 13. Global Extracellular Vesicle Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Extracellular Vesicle Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Extracellular Vesicle Therapy Market Share by Region: 2025 vs 2032
Figure 16. Global Extracellular Vesicle Therapy Market Share by Players in 2025
Figure 17. Global Extracellular Vesicle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Extracellular Vesicle Therapy Revenue in 2025
Figure 19. North America Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Extracellular Vesicle Therapy Market Share by Country (2021–2032)
Figure 21. United States Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Extracellular Vesicle Therapy Market Share by Country (2021–2032)
Figure 25. Germany Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Extracellular Vesicle Therapy Market Share by Region (2021–2032)
Figure 33. China Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Extracellular Vesicle Therapy Market Share by Country (2021–2032)
Figure 41. Mexico Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Extracellular Vesicle Therapy Market Share by Country (2021–2032)
Figure 45. Israel Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Extracellular Vesicle Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 49. EV Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 50. Cellular Biomedicine Group Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 51. Codiak BioSciences Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 52. Coya Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 53. Curexsys Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 54. Evox Therapeutics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 55. ExoCoBio Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 56. ILIAS Biologics Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 57. Rion Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 58. SHIFTBIO Revenue Growth Rate in Extracellular Vesicle Therapy Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
